Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al
1Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain aluzarraga7@gmail.com.
2Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
3Gynecologic Oncology Unit, Obstetrics and Gynecology Department, Hospital de la Santa Creu i Sant Pau Servei d'Obstetricia i Ginecologia, Barcelona, Spain.
4Obstetrics and Gynecology Department, Hospital Universitari General de Catalunya, Barcelona, Catalunya, Spain.
0Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain aluzarraga7@gmail.com.
